Advertisement
NuAire
NuAire

The Scientist

» pharma and developmental biology

Most Recent

image: Mother’s Microbes Protect Baby’s Brain

Mother’s Microbes Protect Baby’s Brain

By | November 19, 2014

Bacteria in the gut of a pregnant mouse strengthen the blood-brain barrier of her developing fetus.

0 Comments

image: Stems Cells Ushered into Embryonic Development

Stems Cells Ushered into Embryonic Development

By | November 7, 2014

The right mix of mouse embryonic stem cells in a dish will start forming early embryonic patterns, according to two studies.

0 Comments

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: Precisely Placed

Precisely Placed

By | September 1, 2014

Vein patterns in the wings of developing fruit flies never vary by more than the width of a single cell.

3 Comments

image: Roche Buys Biotech for $8.3B

Roche Buys Biotech for $8.3B

By | August 27, 2014

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

0 Comments

image: Crayfish Blood Cells Make New Neurons

Crayfish Blood Cells Make New Neurons

By | August 13, 2014

Hemocytes can form neurons in adult crayfish, a study shows.

0 Comments

image: Roche Set to Buy RNAi Firm

Roche Set to Buy RNAi Firm

By | August 6, 2014

The Swiss pharmaceutical giant will reportedly pay $450 million for a Danish biotech company that develops drugs that silence microRNAs.

2 Comments

image: Arrested Development Makes for Long-Lived Worms

Arrested Development Makes for Long-Lived Worms

By | June 23, 2014

Starvation suspends cellular activity in C. elegans larvae and extends their lifespan. 

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Merck Snaps Up Biotech for $3.85B

Merck Snaps Up Biotech for $3.85B

By | June 10, 2014

The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.

0 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Four-legged Snake Fossil Found
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
PDA
PDA
Advertisement